Skip to content

Clinical trials

Observational Leukemia, Hairy Cell trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Leukemia, Hairy Cell Phase: Observational Clear all

37 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20031
20042
20051
20063
20073
20087
20094
20104
20122
20191
20212
20221
20243
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed14
Terminated10
Recruiting5
Unknown status3
Withdrawn3
Active, not recruiting1
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
City of Hope Medical Center3
IRCCS Azienda Ospedaliero-Universitaria di Bologna3
Vanderbilt-Ingram Cancer Center3
Case Comprehensive Cancer Center2
Children's Oncology Group2
UNC Lineberger Comprehensive Cancer Center2
Vanderbilt University2
AstraZeneca1
CHU de Reims1
Eastern Cooperative Oncology Group1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Leukemia, Hairy Cell37
Leukemia, Lymphocytic, Chronic, B-Cell30
Precursor Cell Lymphoblastic Leukemia-Lymphoma25
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative24
Congenital Abnormalities23
Leukemia, Myeloid, Acute23
Leukemia, Myelomonocytic, Chronic22
Lymphoma, B-Cell, Marginal Zone22
Lymphoma, Follicular22
Lymphoma, Large B-Cell, Diffuse22

Trials

Showing 1 to 25 of 37. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.